Treatment of diabetes
   
   

The present invention provides a method of treating insulin-requiring diabetes in a mammal comprising the subcutaneous administration of an effective amount of a glucagon-like peptide 1-related peptide.

 
Web www.patentalert.com

< Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein

< Use of gut-trophic growth factors to improve oxidative status

> Analogues of GLP-1

> Antagonists of intestinotrophic GLP-2 peptides
~ 00184